Imperva Inc. Gets Downgraded to “Perform” at Oppenheimer and Box Ships Prices 5 Million Units at $2.05 a Unit
Imperva Inc. (NYSE: IMPV) was downgraded from "outperform" to “perform” at the firm Oppenheimer. The firm also removed their $65 price target after the company released its Q1 warning. "Our downgrade is driven by negative Q1 pre-announced, driven mainly by U.S. weakness," Oppenheimer analyst Shaul Eyal said. "Increased competition for greater $100 thousand deals, our belief the fixing period this time could exceed a quarter and elevated execution risk as Imperva is also in the midst of integrating two companies acquired in Q4'13," were all factors that led to the ratings downgrade, the